Migration and Head Penetration of Vitamin-E Diffused Cemented Polyethylene Cup in Total Hip Arthroplasty
- Conditions
- Total Hip Arthroplasty
- Interventions
- Device: Vitamin-E diffused polyethylene acetabular componentDevice: Standard polyethylene acetabular component
- Registration Number
- NCT02254980
- Lead Sponsor
- Danderyd Hospital
- Brief Summary
In vitro, Vitamin-E diffused, highly cross-linked polyethylene (PE) have been shown to have superior wear resistance and improved mechanical properties as compared to that of standard highly cross-linked PE. There are as of yet no published studies with vitamin-E diffused PE although several trials are ongoing. All of these trials use uncemented acetabular cups intended for biological fixation. In many countries the standard fixation method for the acetabular component is bone-cement. The Vitamin-E used in implants is alfa-tocopherol, a lipid-soluble antioxidant with oily consistency; theoretically affecting cemented fixation when used in acetabular components. The aim of the study is to compare migration, linear wear and clinical results between two types of cemented acetabular cups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 44
- Primary osteoarthritis of the hip
- Willingness and ability to follow study-protocol
- Inflammatory arthritis or secondary osteoarthritis.
- Type C (stove pipe) femur
- Abnormal femoral or pelvic anatomy after hip dysplasia, not suitable for implantation of components
- Treatment with bisphosphonates, cortisol or cytostatic drugs 6 months prior to surgery
- Ongoing oestrogen treatment
- Not suited for the study for other reason (surgeons preference)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Vitamin-E group Vitamin-E diffused polyethylene acetabular component Vitamin-E diffused polyethylene Control group Standard polyethylene acetabular component Standard polyethylene
- Primary Outcome Measures
Name Time Method Cup migration 2 years The primary outcome measure is migration of the cup at 2 years measured with radiostereometry (RSA) as proximal migration.
- Secondary Outcome Measures
Name Time Method Complication rate 10 years All hip-related complications and revision of implants
Cup migration total 2 years Migration of the cup at 2 years measured with radiostereometry (RSA) as maximum total point motion (MTPM).
Linear wear 4 years Linear head penetration measured with RSA at 4 years
Functional outcome 2 years Hip function measured with Harris hip score
Osteolysis 2 years Development of radiolucent lines between bone and cement around the cup.
Trial Locations
- Locations (1)
Orthopaedic department, Danderyd Hospital
🇸🇪Stockholm, Sweden